Pivotal bioVenture Partners Fund I, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share (OCS)

Filing Manager
Pivotal bioVenture Partners Fund I, L.P.
Reporting Manager
Nan Fung Group Holdings Limited
Security
Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share
Symbol
OCS
Shares outstanding
57,458,694 shares
Disclosed Ownership
2,815,476 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:30:04 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Quoteable Key Fact

"Pivotal bioVenture Partners Fund I, L.P. disclosed 4.9% ownership in Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share (OCS) on 30 Sep 2025."

Quick Takeaways

  • Pivotal bioVenture Partners Fund I, L.P. filed SCHEDULE 13G/A for Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share (OCS).
  • Disclosed ownership: 4.9%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nan Fung Group Holdings Limited 4.9% 2,815,476 0 2,815,476 /s/ Tang Chun Wai Nelson Tang Chun Wai Nelson, Director
NF Investment Holdings Limited 4.9% 2,815,476 0 2,815,476 /s/ Tang Chun Wai Nelson Tang Chun Wai Nelson, Director
Nan Fung Life Sciences Holdings Limited 4.9% 2,815,476 0 2,815,476 /s/ Sun Xintong Sun Xintong, Director
NFLS Platform Holdings Limited 0.9% 514,702 0 514,702 /s/ Sun Xintong Sun Xintong, Director
NFLS Beta Limited 0.9% 514,702 0 514,702 /s/ Sun Xintong Sun Xintong, Director
Pivotal Life Sciences Holdings Limited 4% 2,300,774 0 2,300,774 /s/ Sun Xintong Sun Xintong, Director
Pivotal Partners Ltd 4% 2,300,774 0 2,300,774 /s/ Sun Xintong Sun Xintong, Director
Pivotal bioVenture Partners Fund I U.G.P. Ltd. 4% 2,300,774 0 2,300,774 /s/ Robert Hopfner Robert Hopfner, Authorized Signatory
Pivotal bioVenture Partners Fund I G.P., L.P. 4% 2,300,774 0 2,300,774 /s/ Robert Hopfner By: Pivotal bioVenture Partners Fund I U.G.P. Ltd., its general partner; By: Robert Hopfner, Authorized Signatory
Pivotal bioVenture Partners Fund I, L.P. 4% 2,300,774 0 2,300,774 Pivotal bioVenture Partners Fund I G.P., L.P. its general partner